1.98
price down icon4.35%   -0.09
pre-market  Pre-mercato:  1.90   -0.08   -4.04%
loading

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Income/Loss From Continuing Operations Before Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Net Income/Loss
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.53
price up icon 0.36%
$98.64
price up icon 3.39%
$31.57
price up icon 0.83%
$93.81
price down icon 1.05%
biotechnology ONC
$310.67
price down icon 2.63%
$196.92
price down icon 0.05%
Capitalizzazione:     |  Volume (24 ore):